Mainstream

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments

Post ContentmdtRead More

You might also be interested in reading US Treasury Secretary floats idea of digital dollar maintained by the Fed.

August 19, 2025
In Mainstream